Vinehealth Raises $5.5 Million in Seed Round
Vinehealth, a London-based digital health startup that’s built an app offering personalized support for cancer patients while also making it easier to gather patient-reported outcome (PRO) data, including for drug development and clinical trials, closed a $5.5 million seed round as it prepares to expand into the U.S.
The round, which co-founder and CTO Georgina Kirby describes as a “late seed” — ahead of a planned Series A “in the next 12-18 months” — is led by Talis Capital with participation from previous investors Playfair Capital and Ascension.
Several angel investors have also joined the round, including Keith Gibbs, former CEO of AXA PPP Healthcare; Pam Garside, partner at Newhealth; Voyagers Health-Tech Fund, led by David Rowan, founding editor of Wired; David Giampaolo, healthcare entrepreneur and founder of PI Capital; Deepali Nangia, venture partner at Speedinvest and Atomico Angel; Faisal Mehmud, VP and former medical director of Bristol Myers Squibb; and KHP MedTech Innovations, a collaboration between King’s College London, King’s College Hospital NHS Foundation Trust and Guy’s and St Thomas’ NHS Trust.
Company: Vinehealth Digital Limited
Raised: $5.5M
Round: Seed Round
Funding Month: December 2021
Lead Investors: Talis Capital
Additional Investors: Keith Gibbs, Pam Garside, David Rowan, David Giampaolo, Deepali Nangia, and Faisal Mehmud
Company Website: https://www.vinehealth.ai/
Software Category: AI-driven platform providing support to improve the quality of life and survival of cancer patients
About the Company: Founded in 2018, Vinehealth leverages AI and behavioral science to optimize cancer outcomes through rich patient-generated data. For pharma, Vinehealth provides its platform as a software as a service supporting drug companies in recruiting patients for trials and gathering PRO to help with R&D and drug development. Vinehealth has digitized the traditional paper-based questionnaires that cancer patients would typically be asked to fill in during a visit with their clinical team to report their symptoms and provide any wider feedback.
Source: https://techcrunch.com/2021/12/03/vinehealth-seed/